Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BMY
#126
Bristol-Myers Squibb Company Common Stock
59.3
7
USD
+0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.14%
Monthly Change
+4.16%
6 month change
+5.04%
Year Change
+25.68%
Previous Close
57.5
6
Open
58.9
6
Low
58.9
1
High
59.4
4
Volume
5 188
Markets
US Stock Market
Healthcare
Drug Manufacturers—General
BMY
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
2.24 B
2.18 B
2.1 B
2.02 B
2.03 B
2.04 B
2.04 B
Valuation ratios
Enterprise value
175.17 B
166.54 B
181.91 B
135.05 B
154.13 B
144.78 B
152.59 B
Price to earnings ratio
-15.55
19.98
24.49
13.67
-12.83
15.59
16.14
Price to sales ratio
3.29
3.02
3.36
2.44
2.37
2.28
2.43
Price to cash flow ratio
9.97
8.64
11.87
7.91
7.55
7.77
8.83
Price to book ratio
3.7
3.89
4.99
3.73
7.02
5.95
1.58
Enterprise value to EBITDA ratio
49.92
8.87
10.11
7.42
126.24
10.85
11.57
Profitability ratios
Return on assets %
-0.08
0.06
0.07
0.08
-0.1
0.08
0.03
Return on equity %
-0.24
0.19
0.2
0.27
-0.55
0.38
0.13
Return on invested capital %
-3.74
81.03
87.11
109.15
113.12
38.46
35.26
Gross margin %
72.31
78.57
78.04
76.24
71.08
71.08
70.22
Operating margin %
-43.85
17.46
16.71
18.75
-17.35
19.36
28.19
EBITDA margin %
8.25
40.5
38.97
40.44
2.53
27.68
33.36
Net margin %
-21.2
15.08
13.71
17.83
-18.53
14.64
23.3
Liquidity ratios
Quick ratio
1.47
1.43
1.14
1.31
1.15
1.14
1.28
Current ratio
1.58
1.52
1.25
1.43
1.25
1.26
1.42
Inventory turnover
3.7
4.77
4.57
4.28
5.35
5.18
1.26
Asset turnover
0.34
0.41
0.45
0.47
0.51
0.53
0.13
Solvency ratios
Debt to assets ratio
0.43
0.41
0.41
0.42
0.54
0.5
0.51
Debt to equity ratio
1.34
1.24
1.27
1.35
3.04
2.44
2.22
Long term debt to total assets ratio
0.42
0.41
0.4
0.42
0.53
0.5
0.51
Long term debt to total equity ratio
1.33
1.23
1.25
1.34
3.03
2.43
2.2
Per share metrics
Operating cash flow per share
6.22
7.22
6.09
6.67
7.49
6.94
6.52
EBIT per share
-3.04
3.61
3.59
4.06
-4.13
4.57
4.7
EBITDA per share
1.55
8.37
8.38
8.76
0.6
6.54
6.46
Total debt per share
22.44
19.85
18.32
19.14
24.49
22.12
21.72
Cash per share
8.54
8.46
4.83
6.13
5.5
5.51
5.24
Net current asset value per share
13.37
14.82
12.71
15.29
14.69
14.41
13.29
Tangible book value per share
16.75
16.01
14.47
14.16
8.06
9.06
9.8
Working capital per share
4.92
5.08
2.51
4.58
2.96
2.93
3.93
Book value per share
16.75
16.01
14.47
14.16
8.06
9.06
9.8
News
Undercovered Stocks: SK Hynix, Reddit, Austal, Netlist, And More
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Will Myqorzo Drive Cytokinetics Higher Despite Competitive Pressure?
PRTA Stock Rises Nearly 11% in Six Months: What's Driving It?
Bristol-Myers Squibb’s Q2 2026 Earnings: What to Expect
A New Look At Legend Biotech: Plenty Of Upside For Carvykti (NASDAQ:LEGN)
SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)
My Top 5 Pharma Stocks Wall Street Ignores
Bristol Myers Squibb Stock: Pain First, Payoff Later? (NYSE:BMY)
Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug
Bristol-Myers Squibb: Cash Flow Machine, Growth Portfolio, And Inflation Beating Incomes
House committee investigates Merck, AbbVie over China trials